David Schoenfeld

8PUBLICATIONS
18CO-AUTHORS
Immunogenetics (incl. genetic immunology)Nuclear and plasma physics not elsewhere classifiedMolecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Lilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto

|Jun 02, 2025
PRAME is not a frequently expressed antigen in renal cell carcinoma.

Irvin Yi, Yael Derdikman Ofir, Jacqueline Mann

|Aug 06, 2024
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3.

Oscar Perales, Lucia Jilaveanu, Adebowale Adeniran

|Apr 25, 2024
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.

David G Su, Dijana Djureinovic, David Schoenfeld

|Mar 22, 2024
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.

David G Su, David A Schoenfeld, Wael Ibrahim

|Aug 16, 2023
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.

David A Schoenfeld, Myrto Moutafi, Sandra Martinez

Pageof 2

Frequent Collaborators

6 joint publications

Harriet M Kluger

3 joint publications

David G Su

2 joint publications

David A Braun

2 joint publications

David L Rimm